Infertility impacts 8%-12% of spouses of reproductive age. While male and female factors play a role in 20% of infertility, the rate of male-only infertility is 30%. Azoospermia is present in 10%-15% of infertile men, with 40% of azoospermia cases being obstructive azoospermia and, 60% non-obstructive azoospermia (NOA) (Vander Borght & Wyns, 2018). NOA is a very severe form of male infertility, impacting 5% of infertile spouses. Its aetiology may be genetic, congenital, acquired or idiopathic (Pan et al., 2018). It may not be possible to detect any spermatozoa in the medical and surgical treatment of these patients who undergo a considerably frustrating treatment process (Wyrwoll et al., 2020). Donor spermatozoa may be required for these patients (Corona et al., 2019;Vander Borght et al., 2018).In the meta-analyses, the causes of intermittent azoospermia, cryptospermia, aspermia and severe oligospermia were generally associated with various factors such as seminal tract obstruction, genetic reasons, gonadotoxic exposure, mumps, sexual dysfunction, secondary hypogonadism, varicocele, overweight and chronic diseases (Punab et al., 2017). It was reported that even if azoospermia developed in patients considered to have severe oligospermia associated with intermittent azoospermia, intermittent follow-up semen analyses were required for residual spermatogenesis function (Song et al., 2010). It was emphasized that intermittent azoospermia could be identified when spermatozoon was observed with centrifugation at a rate of 17.9% within six months and beyond in patients who developed NOA following severe oligospermia. It was noted that complete, partial or mixed spermatogenetic activity could be detected